704 related articles for article (PubMed ID: 15194001)
1. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
3. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
4. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
5. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
6. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036.
Shiah HS; Lee WS; Juang SH; Hong PC; Lung CC; Chang CJ; Chou KM; Chang JY
Biochem Pharmacol; 2007 Mar; 73(5):610-9. PubMed ID: 17150195
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
9. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
10. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis.
Müller M; Scaffidi CA; Galle PR; Stremmel W; Krammer PH
Eur Cytokine Netw; 1998 Dec; 9(4):685-6. PubMed ID: 9889415
[TBL] [Abstract][Full Text] [Related]
11. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
12. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
13. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells.
Ali SM; Chee SK; Yuen GY; Olivo M
Int J Mol Med; 2002 Jun; 9(6):601-16. PubMed ID: 12011977
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
16. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
Ruiz-Ruiz C; Muñoz-Pinedo C; López-Rivas A
Cancer Res; 2000 Oct; 60(20):5673-80. PubMed ID: 11059759
[TBL] [Abstract][Full Text] [Related]
18. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
20. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
